291 related articles for article (PubMed ID: 33980221)
1. Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation.
Deng H; Hang Q; Shen D; Zhang Y; Chen M
Cancer Cell Int; 2021 May; 21(1):259. PubMed ID: 33980221
[TBL] [Abstract][Full Text] [Related]
2. High Expression of
Deng H; Huang Y; Wang L; Chen M
Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373
[TBL] [Abstract][Full Text] [Related]
3. Low Expression of ADCY4 Predicts Worse Survival of Lung Squamous Cell Carcinoma Based on Integrated Analysis and Immunohistochemical Verification.
Liu Z; Ru L; Ma Z
Front Oncol; 2021; 11():637733. PubMed ID: 34178627
[TBL] [Abstract][Full Text] [Related]
4. Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics.
Guo W; Sun S; Guo L; Song P; Xue X; Zhang H; Zhang G; Wang Z; Qiu B; Tan F; Xue Q; Gao Y; Gao S; He J
J Cancer Res Clin Oncol; 2020 Apr; 146(4):821-841. PubMed ID: 32103339
[TBL] [Abstract][Full Text] [Related]
5. Identification of pivotal genes associated with the prognosis of gastric carcinoma through integrated analysis.
Ma Z; Xu J; Ru L; Zhu W
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33754626
[TBL] [Abstract][Full Text] [Related]
6. Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases.
Yu Y; Tian X
Medicine (Baltimore); 2020 May; 99(19):e20183. PubMed ID: 32384511
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
Li J; Liu X; Cui Z; Han G
Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
[TBL] [Abstract][Full Text] [Related]
8. Identification of VWF as a Novel Biomarker in Lung Adenocarcinoma by Comprehensive Analysis.
He Y; Liu R; Yang M; Bi W; Zhou L; Zhang S; Jin J; Liang X; Zhang P
Front Oncol; 2021; 11():639600. PubMed ID: 33968738
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis to identify a novel diagnostic marker of lung adenocarcinoma and its immune infiltration landscape.
Zhu A; Pei D; Zong Y; Fan Y; Wei S; Xing Z; Song S; Wang X; Gao X
Front Oncol; 2023; 13():1199608. PubMed ID: 37409245
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Four-Gene Signature Associated with the Prognosis Prediction of Lung Adenocarcinoma Based on Integrated Bioinformatics Analysis.
Wu Y; Yang L; Zhang L; Zheng X; Xu H; Wang K; Weng X
Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205284
[TBL] [Abstract][Full Text] [Related]
11. Weighted gene co-expression network analysis of hub genes in lung adenocarcinoma.
Luo X; Feng L; Xu W; Bai X; Wu M
Evol Bioinform Online; 2021; 17():11769343211009898. PubMed ID: 33911849
[TBL] [Abstract][Full Text] [Related]
12. [Expression and prognosis effect of methylation-regulated SLIT3 and SPARCL1 genes in smoking-related lung adenocarcinoma].
Wang J; Yu XF; Ouyang N; Zhao SY; Guan XF; Yao HP; Chen R; Chen T; Li JX
Zhonghua Yi Xue Za Zhi; 2019 May; 99(20):1553-1557. PubMed ID: 31154721
[No Abstract] [Full Text] [Related]
13. Evaluation of the Prognostic Value of STEAP1 in Lung Adenocarcinoma and Insights Into Its Potential Molecular Pathways via Bioinformatic Analysis.
Guo Q; Ke XX; Liu Z; Gao WL; Fang SX; Chen C; Song YX; Han H; Lu HL; Xu G
Front Genet; 2020; 11():242. PubMed ID: 32265985
[TBL] [Abstract][Full Text] [Related]
14. Identification of key genes and biological pathways in lung adenocarcinoma by integrated bioinformatics analysis.
Zhang L; Liu Y; Zhuang JG; Guo J; Li YT; Dong Y; Song G
World J Clin Cases; 2023 Aug; 11(23):5504-5518. PubMed ID: 37637684
[TBL] [Abstract][Full Text] [Related]
15. Weighted Gene Coexpression Network Analysis of Features That Control Cancer Stem Cells Reveals Prognostic Biomarkers in Lung Adenocarcinoma.
Liao Y; Wang Y; Cheng M; Huang C; Fan X
Front Genet; 2020; 11():311. PubMed ID: 32391047
[No Abstract] [Full Text] [Related]
16. Identification of Six Prognostic Genes in EGFR-Mutant Lung Adenocarcinoma Using Structure Network Algorithms.
Zhang H; Lu D; Li Q; Lu F; Zhang J; Wang Z; Lu X; Wang J
Front Genet; 2021; 12():755245. PubMed ID: 34868228
[TBL] [Abstract][Full Text] [Related]
17. Weighted Gene Co-Expression Network Analysis and Treatment Strategies of Tumor Recurrence-Associated Hub Genes in Lung Adenocarcinoma.
Shen Z; Liu S; Liu J; Liu J; Yao C
Front Genet; 2021; 12():756235. PubMed ID: 34868230
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomic analysis of tumor tissues and organoids reveals the crucial genes regulating the proliferation of lung adenocarcinoma.
Ma X; Yang S; Jiang H; Wang Y; Xiang Z
J Transl Med; 2021 Aug; 19(1):368. PubMed ID: 34446056
[TBL] [Abstract][Full Text] [Related]
19. Chordin-like 1 is a novel prognostic biomarker and correlative with immune cell infiltration in lung adenocarcinoma.
Deng B; Chen X; Xu L; Zheng L; Zhu X; Shi J; Yang L; Wang D; Jiang D
Aging (Albany NY); 2022 Jan; 14(1):389-409. PubMed ID: 35021154
[TBL] [Abstract][Full Text] [Related]
20. Estimation of hub genes and exploration of multi-omics level alterations in the landscape of lung adenocarcinoma.
Li G; Atiq W; Hashmi MF; Ibrahim SS; Al Abdulsalam KA; Kadham MJ; Al-Azzawi AKJ; Aufy M; Abdel-Maksoud MA
Am J Transl Res; 2023; 15(3):1550-1568. PubMed ID: 37056815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
